March 17, 2022
Aaron Glatt, MD, Chairman of the Department of Medicine and Chief of Infectious Diseases/Hospital Epidemiologist at Mount Sinai South Nassau and Clinical Professor of Medicine at the Icahn School of Medicine at Mount Sinai, addressed to MHE the degree obesity is a risk factor at for severe COVID-19 and what those reasons are for obesity increasing the risk. This video is in correlation to Managed Healthcare Executive's March Issue cover story highlighting the dangerous pairing of COVID-19 and Obesity.
March 16, 2022
Their application to the FDA included data showing that confirmed infections and severe illness were lower among individuals who received a second booster of the Pfizer-BioNTech vaccine.
March 15, 2022
Saunders, co-founder at Intellihealth and assistant professor of Clinical Medicine at Weill Cornell Medical College, addressed to MHE the degree obesity is a risk factor at for severe COVID-19 and what those reasons are for obesity increasing the risk. This video is in correlation to Managed Healthcare Executive's March Issue cover story highlighting the dangerous pairing of COVID-19 and Obesity.
March 10, 2022
For now, only the Pfizer and Moderna vaccines have full FDA approval, but many candidates are in phase 2 or 3 trials.
February 24, 2022
With the COVID-19 pandemic ongoing and alarming levels of healthcare workers still experiencing stress, burnout, and other negative feelings surrounding their work, it's time to return the favors they've given countless others.
February 23, 2022
During the state of the industry webinar, AHIP experts reviewed policies and solutions to improve affordable access to care and shape healthcare in the post-pandemic world.
February 17, 2022
An analysis cites increases in bloodstream and urinary tract infections. Hospitals and skilled nursing facilities are seeing more problems.
February 10, 2022
Recent treatment may affect the antibody response, particularly among those with hematologic cancers.
February 09, 2022
“Long COVID” is more likely to affect older people and those who have been hospitalized, but younger people with milder symptoms are not immune to lingering symptoms. One plausible explanation is that the infection results in the activation of autoantibodies.